Ocugen Inc Stock Math Transform Inverse Tangent Over Price Movement
| OCGN Stock | USD 2.48 0.14 5.98% |
| Symbol |
Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Ocugen Inc Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Ocugen price patterns.
Ocugen Technical Analysis Modules
Most technical analysis of Ocugen help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Ocugen from various momentum indicators to cycle indicators. When you analyze Ocugen charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Stock Overview, Methodology & Data Sources
The stock is in a buyout trend.Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing and Bharat Biotech for the commercialization of COVAXIN in the United States market. Ocugen operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 56 people. The profile for Ocugen integrates fundamentals, price behavior, and sector exposure. Historical patterns suggest somewhat reduced sensitivity to broader economic swings. Ocugen has a market cap of 813.19 M, ROE of -7.77%.
Methodology
Unless otherwise specified, financial data for Ocugen Inc is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Ocugen (USA Stocks:OCGN) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: Information for Ocugen Inc is compiled from public filings and market reference sources and official sources including U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Patent & Trademark Office (USPTO). Reporting latency may occur in some cases. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Ocugen Inc may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardBecome your own money manager
Tracking Ocugen inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.
Did you try this?
Run Bond Analysis Now
Bond AnalysisEvaluate and analyze corporate bonds as a potential investment for your portfolios. |
| All Next | Launch Module |
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Driverless Cars Invested few shares | |
 | Baby Boomer Prospects Invested over 20 shares | |
 | Macroaxis Index Invested over 60 shares | |
 | Cash Cows Invested few shares | |
 | Momentum Invested few shares | |
 | Advertising Invested few shares | |
 | Impulse Invested over 200 shares | |
 | Hedge Favorites Invested few shares | |
More Resources for Ocugen Stock Analysis
A structured review of Ocugen Inc often starts with core financial statements and trend context. Ratios and trend metrics help frame Ocugen's operating context. Key reports that frame Ocugen Inc Stock are listed below:Ocugen has a market cap of 813.19 M, operating margin of 85.59%, ROE of -7.77%. Use Your Equity Center to explore allocation context. This includes a position in Ocugen Inc in the portfolio view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census. Analysis related to Ocugen should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Earnings Share -0.23 | Revenue Per Share | Quarterly Revenue Growth 0.542 | Return On Assets | Return On Equity |
The market value of Ocugen Inc is measured differently than book value, which reflects Ocugen accounting equity. Ocugen's market capitalization is 813.19 M. With a P/B ratio of 149.16, the market values Ocugen well above its book equity. Enterprise value stands at 827.76 M. Value and price for Ocugen are related but not identical, and they can diverge across cycles. Trading price represents the transaction level agreed by market participants.
Note that Ocugen's intrinsic value and market price are different measures derived from different inputs. For Ocugen, key inputs include a P/B ratio of 149.16, ROE of -7.77%, and revenue of 4.41 M. Market price reflects the current exchange level formed by active bids and offers.